Morphine Market Trends

  • Report ID: 3602
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Morphine Market Trends

Growth Drivers

  • Expansion of Geriatric Population –. Morphine is widely used as a pain management medication in severe pain. The mostly old population suffers from these kinds of diseases and demands morphine as a pain-relieving medicine.
  • Increasing Support by Government for Opioid Use - Now that governments are also legalizing the use of opioids, increased government support for morphine use in the medical sector, especially in emerging markets, is anticipated to provide lucrative growth opportunities in the predicted period.
  • High Demand in Pharmaceutical Sector - It is used in the pharmaceutical industry to develop new drugs due to its multiple properties such as appetite stimulation, inflammation relief, nausea relief, epileptic seizure control, and treatment of psychiatric disorders. According to the Congressional Budget Office, the new drugs approved for sale raised by 60 percent between 2010 and 2019 in the United States.
  • Escalating Presence of Musculoskeletal Disorder – The prevalence of musculoskeletal diseases is at a high rate across the globe which further is expected to raise the demand for its medication thus driving the morphine market growth in the estimated period. Approximately 1.71 billion people worldwide suffer from musculoskeletal disorders, as per the February 2021 report by WHO. 

Challenges

  • Concern Regarding the Misuse of Morphine – Morphine is a type of drug that can become addictive if used for a long period of time or in high quantity. Few individuals might use morphine as the mode of addiction and it becomes very difficult to get over this addiction. Therefore, when it becomes addiction people start misusing this morphine medication and it becomes harmful to an individual’s health. This is estimated to pose a limitation on the morphine market expansion in the upcoming future.  
  • Production Challenges
  • Standards Put Forward by Government

Global Morphine Market: Key Insights

 

Base Year

2024

Forecast Year

2025-2037

CAGR

6.7%

Base Year Market Size

USD 17.27 billion

Forecast Year Market Size

USD 40.13 billion

Regional Synopsis

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3602
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of morphine is assessed at USD 18.2 billion.

The morphine market size was over USD 17.27 billion in 2024 and is projected to reach USD 40.13 billion by 2037, growing at around 6.7% CAGR during the forecast period i.e., between 2025-2037. The growing application of medical morphine as a pain killer is estimated to boost market growth.

North America industry is predicted to dominate majority revenue share of 35% by 2037, due to increasing patient pool of osteoporosis in the region.

The major players in the market include Verve Health Care Ltd., Mayne Pharma Group, Daiichi Sankyo Company Limited, Hikma Pharmaceuticals USA, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Alcaliber S.A., Mallinckrodt Pharmaceuticals, AstraZeneca plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample